DV
Dividend Vision

CRL — Charles River Laboratories International Inc.

Charles River Laboratories International Inc. (CRL)

Total return is 1173.0% over the past 26.1 years, 419.0 points ahead of SPY at 754.0%. Its deepest 1-year drawdown was 33.9%.

CRL is an equity stock focused on Charles River Laboratories International Inc., a single-company holding rather than a diversified fund. It distributes earnings on a quarterly basis and is tagged as a dividend-paying security, though specific yield and expense ratio data are not currently available. This holding appeals primarily to investors seeking concentrated exposure to a specific company's dividend payments rather than broad portfolio diversification.

CRL key facts

Asset type
Stock
Asset class
Equity
Inception date
06/23/2000
Distribution frequency
None
Last close
$280.05
Market cap
$13,369,270,272
Average volume
750400.0
Beta
1.376
Payout ratio
0.0
Forward P/E
24.9377
EPS
$-4.81